The Jumonji-C oxygenase JMJD7 catalyzes (3S)-lysyl hydroxylation of TRAFAC GTPases
- Nat Chem Biol. 2018 Jul;14(7):688-695. doi: 10.1038/s41589-018-0071-y.
- 1. Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, UK.
- 2. Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
- 3. Instituto Leloir, Buenos Aires, Argentina.
- 4. Target Discovery Institute, University of Oxford, Oxford, UK.
- 5. The Francis Crick Institute, London, UK.
- 6. Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, UK. [email protected].
- 7. Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Clark Center, Stanford, CA, USA. [email protected].
- 8. Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. [email protected].
- 9. Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, UK. [email protected].
Biochemical, structural and cellular studies reveal Jumonji-C (JmjC) domain-containing 7 (JMJD7) to be a 2-oxoglutarate (2OG)-dependent oxygenase that catalyzes (3S)-lysyl hydroxylation. Crystallographic analyses reveal JMJD7 to be more closely related to the JmjC hydroxylases than to the JmjC demethylases. Biophysical and mutation studies show that JMJD7 has a unique dimerization mode, with interactions between monomers involving both N- and C-terminal regions and disulfide bond formation. A proteomic approach identifies two related members of the translation factor (TRAFAC) family of GTPases, developmentally regulated GTP-binding proteins 1 and 2 (DRG1/2), as activity-dependent JMJD7 interactors. Mass spectrometric analyses demonstrate that JMJD7 catalyzes Fe(II)- and 2OG-dependent hydroxylation of a highly conserved lysine residue in DRG1/2; amino-acid analyses reveal that JMJD7 catalyzes (3S)-lysyl hydroxylation. The functional assignment of JMJD7 will enable future studies to define the role of DRG hydroxylation in cell growth and disease.